We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PetMed Express (PETS - Free Report) is a Zacks Rank #1 (Strong Buy) and has a growth style score of A - all of that puts the stock in my radar screen. Thing is, I have been watching this stock since the summer time when a short attack hit the stock and caused some wild swings.
PetMed Express is a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats to retail customers. PetMed Express was founded in 1996 and is headquartered in Delray Beach, Florida.
Estimates
The stock is a Zacks Rank #1 (Strong Buy) because earnings estimates have moved higher. The Zacks Consensus Estimate for 2017 has moved from $1.42 to $1.68 over the last sixty days.
The Zacks Consensus Estimate for 2018 also increased over the same time period. The number moved from $1.51 to $1.80.
Short Interest
There is a huge short interest in this stock. That means that investors believe that the stock will move lower and they have borrowed shares, sold them and hope to buy them back lower. Thing is, the short is not working. The site ShortSqueeze.com shows that the float is 30% short... and that is a huge amount of shorts.
As fundamentals continue to improve, the shorts are more likely to cover their bets and take a loss. This is could be a classic short squeeze.
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
Bull Of The Day: PetMed Express (PETS)
PetMed Express (PETS - Free Report) is a Zacks Rank #1 (Strong Buy) and has a growth style score of A - all of that puts the stock in my radar screen. Thing is, I have been watching this stock since the summer time when a short attack hit the stock and caused some wild swings.
Previous Video
Back on September 7, I filmed this video which focuses on Aggressive Growth stocks. You can access the video on this page (https://www.zacks.com/stock/news/275015/petmed-express-and-crox-are-aggressive-growth-rank-buys) and also hear about CROX as well.
Description
PetMed Express is a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats to retail customers. PetMed Express was founded in 1996 and is headquartered in Delray Beach, Florida.
Estimates
The stock is a Zacks Rank #1 (Strong Buy) because earnings estimates have moved higher. The Zacks Consensus Estimate for 2017 has moved from $1.42 to $1.68 over the last sixty days.
The Zacks Consensus Estimate for 2018 also increased over the same time period. The number moved from $1.51 to $1.80.
Short Interest
There is a huge short interest in this stock. That means that investors believe that the stock will move lower and they have borrowed shares, sold them and hope to buy them back lower. Thing is, the short is not working. The site ShortSqueeze.com shows that the float is 30% short... and that is a huge amount of shorts.
As fundamentals continue to improve, the shorts are more likely to cover their bets and take a loss. This is could be a classic short squeeze.
Chart
PetMed Express, Inc. Price and Consensus
PetMed Express, Inc. Price and Consensus | PetMed Express, Inc. Quote
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>